Skip to main content
Quest Diagnostics

Real World Use of Plasma Beta Amyloid 42/40 and p-tau217 in Alzheimer’s Disease

AAN 2026

Congress of the European Society of Clinical Microbiology and Infectious Diseases

Chicago, IL, April 18-22, 2026

Poster presentation: Real World Use of Plasma Beta Amyloid 42/40 and p-tau217 in Alzheimer’s Disease

Authors: Racke MK, Chen Z, Stroh M, Weber DM

Medical Specialty: Neurology

Related content

Publication
Cost-Effectiveness Analysis of Blood-Based Biomarker Testing in the Diagnosis of Alzheimer’s Disease Pathology
Publication
Development and Clinical Validation of Blood-Based Multibiomarker Models for the Evaluation of Brain Amyloid Pathology
Audio Podcast
Integrating Blood-Based Biomarkers for Alzheimer’s Risk Assessment
On-Demand Webinar
The Evolving Role of Biomarkers in Alzheimer’s Evaluation
Live Webinar
Advancing Alzheimer's Diagnostics with the Power of Combined Plasma Biomarkers
Publication
Clinical Utility of Plasma Aβ42/40 Ratio by LC-MS/MS in Alzheimer’s Disease Assessment
Publication
EXPRESS: New Plasma LC-MS/MS Assays for the Quantitation of Beta-amyloid Peptides and Identification of Apolipoprotein E Proteoforms for Alzheimer’s Disease Risk Assessment
Publication
Diffusion MRI Relates to Plasma Aβ42/40 in PET Negative Participants Without Dementia

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.